[Mutations in mitochondrial DNA associated with hypertension]

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Disease

Context:

• Mitochondrial DNA (mtDNA) mutations are increasingly recognized as contributors to complex diseases.
• Essential hypertension has a multifactorial etiology, including genetic and environmental factors.
• Specific mtDNA mutations affecting tRNA function have been implicated in various pathologies.

Purpose:

• To review the association between specific mitochondrial DNA mutations and essential hypertension.
• To elucidate the molecular mechanisms by which these mutations contribute to hypertension.
• To highlight the potential of mtDNA mutations as inherited risk factors for hypertension.

Summary:

• Specific mutations in mitochondrial tRNAs (e.g., tRNAMet A4435G, tRNAIle A4263G) are associated with essential hypertension.
• These mutations disrupt tRNA metabolism, impair mitochondrial protein synthesis, and compromise oxidative phosphorylation.
• This leads to reduced ATP synthesis and increased reactive oxygen species, contributing to hypertension development.

Impact:

• Provides insights into the molecular mechanisms underlying maternally inherited hypertension.
• Suggests mtDNA mutations as potential biomarkers for hypertension risk assessment.
• Opens avenues for novel therapeutic strategies targeting mitochondrial dysfunction in hypertension management.